INTAGE : Summary of Consolidated Financial Results for the Nine Months Ended March 31, 2026 (Japanese GAAP)293KB

Summary of Consolidated Financial Results

for the Nine Months Ended March 31, 2026 (Japanese GAAP)

Company name: INTAGE HOLDINGS Inc. Stock exchange listing: Tokyo

Code number: 4326 URL https://www.intageholdings.co.jp/ Representative: Yoshiya Nishi, President and Representative Director

Contact person: Toru Takeuchi, Director TEL: +81-3-5294-7411 Planned start of dividend payments: -

Preparation of supplementary explanations of financial results: Yes Financial results presentation held: No

May 7, 2026

(Amounts are rounded off to nearest million yen.)

1. Consolidated Financial Results for the Nine Months Ended March 31, 2026 (July 1, 2025 to March 31, 2026 )

   1. Consolidated Operating Results (Cumulative) (Percentages indicate year-on-year changes.)

      	Net sales		Operating profit		Ordinary profit		Profit attributable to owners of parent
      	Millions of yen	%	Millions of yen	%	Millions of yen	%	Millions of yen	%
      Nine months ended March 31, 2026	51,874	1.8	5,568	30.5	5,604	33.4	3,414	-9.8
      Nine months ended March 31, 2025	50,945	5.4	4,267	29.0	4,201	18.2	3,784	58.1

      (Note) Comprehensive income: Nine months ended March 31, 2026: 3,722 million yen (-4.3%)

      Nine months ended March 31, 2025: 3,888 million yen (49.9%)

      	Profit per share	Profit per share after dilution
      	Yen	Yen
      Nine months ended March 31, 2026	89.39	-
      Nine months ended March 31, 2025	99.16	-

      (Note) For the purpose of calculating profit per share, the number of shares of the Company held in trust for directors' compensation was included in the number of treasury shares, which was to be deducted from the calculation of the average number of shares during the period.

   2. Consolidated Financial Position

   	Total assets	Net assets	Equity ratio
   	Millions of yen	Millions of yen	%
   As of March 31, 2026	48,767	35,259	71.9
   As of June 30, 2025	46,922	33,321	70.6

   (Reference) Total shareholders' equity: As of March 31, 2026: 35,049 million yen

   As of June 30, 2025: ¥33,128 million

2. Dividends

   	Dividend per share
   	1Q-end	2Q-end	3Q-end	Year-end	Total
   	Yen	Yen	Yen	Yen	Yen
   Year ended June 30, 2025	-	22.50	-	22.50	45.00
   Year ending June 30, 2026	-	24.00	-
   Year ending June 30, 2026 (Forecast)				24.00	48.00

   (Note) Revisions to the most recently disclosed dividend forecasts: None

3. Consolidated Earnings Forecasts for the Fiscal Year Ending June 30, 2026 (July 1, 2025 to June 30, 2026)

   (Percentages indicate year-on-year changes.)

   	Net sales		Operating profit		Ordinary profit		Profit attributable to owners of parent		Profit per share
   Full year	Millions of yen	%	Millions of yen	%	Millions of yen	%	Millions of yen	%	Yen
   	70,000	6.8	5,600	32.0	5,500	33.1	3,200	-8.7	83.80

   (Note) Revisions to the most recently disclosed earnings forecasts: None

   • Notes

     1. Significant changes in the scope of consolidation during the period: No Newly included: - Excluded: -

     2. Application of Accounting Treatment Specific to the Preparation of Quarterly Consolidated Financial Statements:

        Yes

     3. Changes in accounting policies, changes in accounting estimates and restatement of prior period financial statements:

        1. Changes in accounting policies due to revisions to accounting standards and other regulations: None

        2. Changes in accounting policies due to other reasons: None

        3. Changes in accounting estimates: None

        4. Restatement of prior period financial statements: None

     4. Number of shares issued and outstanding (common shares)

        1) Number of shares issued at the end of the period (including treasury shares)	As of March 31, 2026	40,426,000	As of June 30, 2025	40,426,000
        2) Number of treasury shares at the end of the period	As of March 31, 2026	2,215,670	As of June 30, 2025	2,237,920
        3) Average number of shares during the period (cumulative from the beginning of the fiscal year)	Nine months ended March 31, 2026	38,202,660	Nine months ended March 31, 2025	38,164,462

   • Review of the accompanying quarterly consolidated financial statements by a certified public accountant or an auditing corporation: None

   • Explanation on the appropriate use of earnings forecasts and other special notes

The forward-looking statements made in this document, including the earnings forecasts, are based on information currently available to the Company and on certain assumptions deemed to be reasonable by the Company. Actual performance and other results may differ materially owing to various factors.

• Table of Contents of the Attached Material

  1. Overview of Consolidated Financial Results, etc 2

     1. Overview of Consolidated Financial Results for the Nine Months Ended March 31, 2026 2

     2. Overview of Financial Position for the Nine Months Ended March 31, 2026 3

  2. Consolidated Financial Statements and Notes Thereto 5

     1. Consolidated Balance Sheet 5

     2. Consolidated Statements of Income and Consolidated Statements of Comprehensive Income 7

     3. Notes to Quarterly Consolidated Financial Statements 9

(Application of accounting treatment specific to the preparation of

quarterly consolidated financial statements) 9

(Notes on segment information, etc.) 9

(Note in the event of major change in shareholders' equity) 10

(Note on assumptions for going concern) 10

(Notes on statement of cash flows) 10

1. ‌Overview of Consolidated Financial Results, etc.

   1. ‌Overview of Consolidated Financial Results for the Nine Months Ended March 31, 2026

      During the nine months under review (July 1, 2025 to March 31, 2026), the Japanese economy was expected to maintain a modest recovery, partly due to various government policies while the employment and income environment improved. In addition, looking at the economies of the Asian region where the Group operates, China is expected to continue its gradual slowdown, although there are signs of recovery and improvement in other countries.

      Meanwhile, downside risks to the economy were a concern, including the impact of developments in the Middle East, volatility in financial capital markets, and trends surrounding U.S. trade policy.

      In order to realize the basic group policy of the 14th Medium-Term Management Plan, "Towards New Portfolio as a Data

      + Technology Company - Creation of New Value," the Group has set the basic policy of "Growth with Optimization" for the consolidated fiscal year under review, the final year of the plan. The Group will shift to business operations that clearly define core businesses and growth businesses and promote a shift to an optimal formation, including the consolidation and elimination of organizations and functions to enhance the Group's overall strength. As a consequence, the Group will promote the shift from decentralization to integration, build an organizational structure that facilitates the optimal allocation of management resources, and advance resource allocation toward businesses with promising medium-to long-term growth prospects.

      The Company has increased the number of Executive Officers effective July 1, 2025. By appointing human resources with expertise and experience in each business field to manage the Company in a concentrated manner, the Group aims to accelerate the speed of its growth by creating businesses through collaboration among businesses and expanding business domains beyond segments, thereby speeding up decision-making related to business execution and maximizing the Group's management.

      At the same time, we will strive to improve management transparency and strengthen corporate governance by securing diverse management personnel and their participation, as well as develop next-generation leaders and future management team members to achieve sustainable growth.

      In the Marketing Support (Consumer Goods & Services) business, we expect solid growth in panel and custom research, our core business, and aim to further improve profitability through process innovation by increasing the value provided to clients and utilizing generative AI. As a growth area, we will also redesign our marketing solutions business in collaboration with NTT DOCOMO, Inc. to promote data utilization consulting and strengthen our CX management system and infrastructure.

      In the Marketing Support (Healthcare) business, we will expand our business into new areas such as promotion, communication to become a decision-making partner in healthcare. We will also promote efforts to create new value based on a patient-centric*1 perspective.

      We will also accelerate our efforts to improve operational efficiency and exceed customer expectations through the use of AI and Group assets.

      In the Business Intelligence business, under the basic policy of "becoming the DX partner of choice for the next 10 years," we will accelerate business growth by continuing to expand the data integration platform and utilization business, solidify our business foundation by strengthening our planning, proposal, and project promotion capabilities, and establish a stock business that provides solutions to common industry issues.

      The group as a whole is promoting optimization of core businesses and growth of growing businesses, while continuing to strengthen capital policies based on a stable financial base, create businesses through inter-group collaboration, implement measures to increase non-financial capital such as human capital, and enhance sustainability.

      As a result of these efforts, the INTAGE Group's consolidated net sales for the nine months under review amounted to

      ¥51,874 million (up 1.8% from the same period of the previous year), with an operating profit of ¥5,568 million (up 30.5%), ordinary profit of ¥5,604 million (up 33.4%), and profit attributable to owners of parent of ¥3,414 million (down 9.8%).

      The results by business segment are described below.

      1. Marketing Support (Consumer Goods & Services)

         In the Marketing Support (Consumer Goods & Services) segment, both sales and profit increased; consolidated net sales of the segment amounted to ¥36,841 million (up 4.2% from the same period of the previous year), with an operating profit of ¥2,791 million (up 55.0%)

         In this segment, panel surveys and custom research, our core business, performed well. Meanwhile, the marketing solutions area, growth business collaborated with NTT DOCOMO, Inc, achieved year-on-year gains. On the other hand, INTAGE Research Inc. posted a decline in sales due to the absence of large projects in the previous year.

         Profits increased due to increased sales from panel surveys and custom research, as well as a decrease in investment expenses.

      2. Marketing Support (Healthcare)

         In the Marketing Support (Healthcare) segment, sales decreased but profit increased; consolidated net sales of the segment amounted to ¥9,565 million (down 0.4% from the same period of the previous year), with an operating profit of ¥2,277 million (up 26.2%).

         In this segment, sales were at the previous year's level due to the strong performance of INTAGE Healthcare Inc.'s mainstay research business and Intage Real World, Inc. despite the impact of the sale of the CRO business of INTAGE Healthcare Inc.

         Profits increased on higher sales in high-margin research businesses.

      3. Business Intelligence

         In the Business Intelligence segment, both sales and profit decreased; consolidated net sales of the segment amounted to

         ¥5,467 million (down 8.6% from the same period of the previous year), with an operating profit of ¥499 million (down 24.5%).

         Although one-time expenses incurred in connection with the integration and relocation of the Nagano office in November 2025 were a factor in the decline in profits, both sales and operating profit were at the planned levels for the business.

         In this business, while INTAGE TECHNOSPHERE Inc. recorded steady sales in the data integration platform and utilization business, a priority area for the company, Buildsystem Co., Ltd. recorded a year-on-year decline in sales due to a reactionary drop from the brisk low-code development projects in the previous year.

         Profitability has improved due to pricing revisions and operational efficiencies, but remains below the previous year's level given lower sales and one-time expenses incurred.

         *1 Patient Centricity: A concept that places the highest priority on patients' perspectives and needs in the provision of medical services and the development of pharmaceutical products

   2. ‌Overview of Financial Position for the Nine Months Ended March 31, 2026

   (Assets)

   Current assets increased ¥1,686 million from the end of the previous fiscal year to ¥32,220 million. This increase was mainly due to a rise in notes and accounts receivable - trade, and contract assets by ¥5,664million, while cash and deposits decreased by ¥4,698 million.

   Non-current assets increased ¥158 million from the end of the previous fiscal year to ¥16,547 million. This was mainly due to a ¥514 million increase in other intangible assets and a ¥286 million increase in other investments and other assets, despite a ¥345 million decrease in buildings and structures, net, a ¥248 million decrease in goodwill, and a ¥320 million decrease in investment securities.

   As a result, total assets increased by ¥1,845 million to ¥48,767 million. (Liabilities)

   Current liabilities decreased ¥162 million from the end of the previous fiscal year to ¥12,404 million. This was mainly due to a ¥719 million decrease in provision for bonuses, which was partially offset by a ¥317 million increase in accounts payable-trade and a ¥254 million increase in other.

   Non-current liabilities increased ¥70 million from the end of the previous fiscal year, to ¥1,104 million. This was mainly

   due to increases of ¥26 million in lease liabilities and ¥25 million in retirement benefit liability. As a result, total liabilities decreased by ¥92 million to ¥13,508 million.

   (Net assets)

   Total net assets increased by ¥1,938 million from the end of the previous fiscal year to ¥35,259 million. This was largely due to an increase of ¥1,624 million in retained earnings.

2. ‌Consolidated Financial Statements and Notes Thereto

1. ‌Consolidated Balance Sheet

   (Thousands of yen)

   Previous consolidated fiscal year (As of June 30, 2025)		Third quarter under review (As of March 31, 2026)
   Assets
   Current assets
   Cash and deposits	15,269,232	10,571,005
   Notes and accounts receivable - trade, and contract assets	10,030,855	15,695,084
   Merchandise	21,923	8,788
   Work in process	1,773,681	1,778,900
   Supplies	79,753	87,245
   Other	3,365,794	4,086,766
   Allowance for doubtful accounts	-7,895	-7,568
   Total current assets	30,533,345	32,220,221
   Non-current assets
   Property, plant and equipment
   Net buildings and structures	1,326,190	981,181
   Net equipment and fixtures	368,727	411,504
   Land	1,998,156	1,998,156
   Net leased assets	207,915	223,169
   Total property, plant and equipment	3,900,989	3,614,011
   Intangible assets
   Goodwill	2,568,963	2,320,463
   Other	3,173,261	3,688,176
   Total intangible assets	5,742,224	6,008,640
   Investments and other assets
   Investment securities	2,561,762	2,241,266
   Deferred tax assets	1,477,774	1,580,139
   Retirement benefit assets	1,111,165	1,242,499
   Other	1,879,095	2,165,909
   Allowance for doubtful accounts	-283,698	-304,977
   Total investments and other assets	6,746,098	6,924,837
   Total non-current assets	16,389,313	16,547,489
   Total assets	46,922,658	48,767,711

   (Thousands of yen)

   Previous consolidated fiscal year (As of June 30, 2025)		Third quarter under review (As of March 31, 2026)
   Liabilities
   Current liabilities
   Accounts payable - trade	2,703,933	3,021,237
   Current portion of long-term loans payable	100,000	-
   Lease liabilities	120,687	109,200
   Income taxes payable	1,231,767	1,310,819
   Provision for bonuses	2,315,670	1,596,502
   Provision for point card certificates	2,275,174	2,292,293
   Other	3,819,902	4,074,104
   Total current liabilities	12,567,135	12,404,156
   Non-current liabilities
   Lease liabilities	118,887	145,323
   Provision for share awards	132,864	134,851
   Retirement benefit liability	294,355	319,900
   Asset retirement obligations	397,222	399,986
   Other	91,139	104,433
   Total non-current liabilities	1,034,470	1,104,494
   Total liabilities	13,601,605	13,508,650
   Net assets
   Shareholders' equity
   Share capital	2,378,706	2,378,706
   Capital surplus	1,796,274	1,796,274
   Retained earnings	31,961,063	33,585,228
   Treasury shares	-3,334,616	-3,317,001
   Total shareholders' equity	32,801,428	34,443,207
   Accumulated other comprehensive income
   Valuation difference on available-for-sale securities	-12,747	69,044
   Foreign currency translation adjustment	700,872	872,403
   Remeasurements of defined benefit plans	-360,639	-335,166
   Total accumulated other comprehensive income	327,485	606,282
   Non-controlling interests	192,139	209,570
   Total net assets	33,321,053	35,259,060
   Total liabilities and net assets	46,922,658	48,767,711

2. ‌Consolidated Statements of Income and Consolidated Statements of Comprehensive Income

   Consolidated Statements of Income For the nine months ended March

   (Thousands of yen)

   Nine months ended March 31, 2025 (July 1, 2024 to March 31, 2025)		Nine months ended March 31, 2026 (July 1, 2025 to March 31, 2026)
   Net sales	50,945,936	51,874,949
   Cost of sales	31,801,262	30,753,976
   Gross profit	19,144,674	21,120,972
   Selling, general and administrative expenses	14,876,910	15,552,113
   Operating profit	4,267,764	5,568,858
   Non-operating income
   Interest income	19,903	30,876
   Dividend income	9,202	7,048
   Share of profit of entities accounted for using equity method	5,516	4,820
   Insurance claim and dividend income	28,195	26,919
   Reversal of allowance for doubtful accounts	27,634	-
   Foreign exchange gains	-	40,104
   Other	44,474	31,355
   Total non-operating income	134,925	141,124
   Non-operating expenses
   Interest expenses	6,158	4,836
   Loss on investments in investment partnerships	61,039	37,818
   Loss on retirement of non-current assets	14,500	27,223
   Foreign exchange gains	111,009	-
   Provision of allowance for doubtful accounts	-	23,544
   Other	8,921	11,641
   Total non-operating expenses	201,629	105,064
   Ordinary profit	4,201,060	5,604,918
   Extraordinary income
   Gain on sale of investment securities	197,643	21,994
   Gain on sale of businesses	1,588,041	-
   Total extraordinary income	1,785,685	21,994
   Extraordinary losses
   Impairment losses	-	342,099
   Loss on valuation of investment securities	382,626	76,999
   Other	20,000	-
   Total extraordinary losses	402,626	419,099
   Profit before income taxes	5,584,119	5,207,813
   Income taxes	1,793,795	1,772,600
   Profit	3,790,324	3,435,213
   Profit attributable to non-controlling interests	6,124	20,240
   Profit attributable to owners of parent	3,784,200	3,414,972

   Consolidated Statements of Comprehensive Income

   For the nine months ended March

   (Thousands of yen)

   Nine months ended March 31, 2025 (July 1, 2024 to March 31, 2025)		Nine months ended March 31, 2026 (July 1, 2025 to March 31, 2026)
   Profit	3,790,324	3,435,213
   Other comprehensive income
   Valuation difference on available-for-sale securities	-12,212	79,816
   Foreign currency translation adjustment	110,648	181,614
   Remeasurements of defined benefit plans, net of tax	-469	25,473
   Total of other comprehensive income	97,965	286,903
   Comprehensive income	3,888,290	3,722,116
   Comprehensive income attributable to
   Comprehensive income attributable to owners of parent	3,871,677	3,693,769
   Comprehensive income attributable to non-controlling interests	16,612	28,347

3. ‌Notes to Quarterly Consolidated Financial Statements

‌(Application of accounting treatment specific to the preparation of quarterly consolidated financial statements)

Tax expenses are calculated by multiplying income before income taxes by an effective tax rate, which is reasonably estimated by applying tax-effect accounting to estimated income before income taxes for the fiscal year including the third quarter under review.

‌(Notes on segment information, etc.)

I For the nine months ended March 31, 2025 (July 1, 2024 to March 31, 2025)

Information on the amounts of net sales and profit by reportable segment

(Note) The total of the segment profit equals the operating profit reported in the consolidated statements of income.

2. Information on impairment loss of non-current assets, amortization of goodwill and unamortized balance by reportable segment

‌(Significant changes in amount of goodwill)

In the Marketing Support (Consumer Goods & Services) segment, shares of DOCOMO InsightMarketing, INC. were acquired and included in the scope of consolidation. This event resulted in an increase in goodwill of ¥2,198,676 thousand during the nine months under review.

II. For the nine months ended March 31, 2026 (July 1, 2025 to March 31, 2026)

Information on the amounts of net sales and profit by reportable segment

(Note) The total of the segment profit equals the operating profit reported in the consolidated statements of income.

2. Information on impairment loss of non-current assets, amortization of goodwill and unamortized balance by reportable segment

(Important impairment loss on non-current assets)

Impairment losses on non-current assets were recorded in the Business Intelligence segment. For the first six months of the fiscal year under review, the value of impairment losses was ¥334,586 thousand

‌(Note in the event of major change in shareholders' equity) Not applicable.

‌(Note on assumptions for going concern) Not applicable.

‌(Notes on statement of cash flows)

The Company did not prepare quarterly consolidated statement of cash flows for the first nine months of the fiscal year under review. Depreciation (including amortization of intangible assets, excluding amortization of goodwill) and amortization of goodwill for the first nine months under review are as follows.